| Literature DB >> 30450460 |
Sree K Venuthurupalli1,2, Andrea Rolfe3, John Fanning1, Anne Cameron2, Wendy E Hoy2.
Abstract
INTRODUCTION: Enabled by the Chronic Kidney Disease, Queensland (CKD.QLD) Registry, we aim to outline the structure, implementation, and outcomes of telenephrology clinics for the management of patients with chronic kidney disease (CKD) in rural, regional, and remote areas of the Darling Downs region in Queensland, Australia.Entities:
Keywords: chronic kidney disease; telenephrology
Year: 2018 PMID: 30450460 PMCID: PMC6224628 DOI: 10.1016/j.ekir.2018.07.013
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
Figure 1Geographical coverage of renal specialist clinics within the Darling Downs Hospital and Health Service. Maps not to scale.
Figure 2Location and distribution of telenephrology clinics across the health service. SWHHS, South West Hospital and Health Service. The basic map was sourced from the website of Department of Health’s Primary Health Networks, with permission.
Baseline characteristics of the telenephrology cohort versus the standard care cohort
| Parameter | Telenephrology cohort | Standard care cohort | |
|---|---|---|---|
| No. of patients | 234 (22.3) | 817 (77.7) | |
| Sex: male/female | 124/110 | 458/359 | 0.40 |
| No. of Aboriginal patients | 52 (22.2) | 49 (5.9) | 0.001 |
| Age at consent (yr) | 65.1 ± 13.4 | 63.5 ± 15.6 | 0.36 |
| Obesity (BMI ≥ 30 kg/m2) | 127 (54.2) | 407 (49.8) | 0.22 |
| Elderly (age ≥ 70 yr) | 100 (42.7) | 349 (42.7) | 0.99 |
| Advanced CKD (stages 4 and 5) | 77 (32.9) | 313 (38.3) | 0.15 |
| eGFR at consent (ml/min per 1.73 m2) | 40.4 ± 20.8 | 40.3 ± 22.8 | 0.68 |
| Hypertension | 213 (93.1) | 739 (90.4) | 0.20 |
| Diabetes | 130 (55.5) | 336 (41.1) | 0.001 |
| Smoking status | 146 (62.3) | 458 (56.0) | 0.08 |
| Diabetic nephropathy | 83 (35.4) | 198 (24.2) | 0.001 |
| Cardiac disease | 106 (45.3) | 334 (40.8) | 0.22 |
| Coronary artery disease | 63 (26.9) | 198 (24.2) | 0.40 |
| Cerebrovascular disease | 28 (11.9) | 103 (12.6) | 0.79 |
| Peripheral vascular disease | 23 (9.8) | 72 (8.7) | 0.75 |
| Cancers | 47 (20.0) | 197 (24.1) | 0.37 |
| Psychiatric disorders | 14 (5.9) | 48 (5.8) | 0.86 |
| Depression | 47 (20.0) | 161 (19.7) | 0.86 |
| Gastroesophageal reflux | 53 (22.6) | 147 (17.9) | 0.24 |
| Gout | 61 (26.0) | 188 (23.0) | 0.47 |
| Arthritis | 74 (31.6) | 185 (22.6) | 0.01 |
| Metabolic bone disease | 19 (8.1) | 81 (9.9) | 0.61 |
| Musculoskeletal problems | 44 (18.8) | 130 (15.9) | 0.50 |
| Joint replacement | 19 (8.1) | 54 (6.6) | 0.63 |
| Thyroid disorders | 35 (14.9) | 107 (13.1) | 0.66 |
| Eye disorders | 28 (11.9) | 79 (9.6) | 0.30 |
| Chronic lung disease | 42 (17.9) | 116 (14.2) | 0.15 |
| Obstructive sleep apnea | 27 (11.5) | 109 (13.3) | 0.66 |
Data are mean ± SD or n (%).
BMI, body mass index; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.
The telenephrology cohort has more Aboriginal patients, diabetes, diabetic nephropathy, and arthritis.
Significance: P < 0.05.
Important clinical outcomes in the 2 cohorts
| Outcome | Telenephrology cohort | Standard care cohort |
|---|---|---|
| RAAS blockers | 176 (75.2) | 578 (70.5) |
| Lipid-lowering drugs | 170 (72.6) | 541 (66.2) |
| Clinic attendance rate (%) | 90 | 93 |
| Hospital admissions (per patient) | 1.63 | 2.25 |
| Mean length of stay (d) | 5.5 | 4.0 |
| Renal replacement therapy | 12 (5.1) | 81(9.9) |
| Overall mortality | 26 (11.1) | 149 (18.2) |
Data are n (%) unless indicated otherwise.
RAAS, renin-angiotensin-aldosterone system.
Significant.